Zhenpeng Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhenpeng Peng has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jifei Wang
Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication - Ling Xu
Faculty of Medicine and Dentistry, University of Western Australia, Perth, Australia
1 shared publication - Mengqi Huang
Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China
1 shared publication - Mimi Tang
Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China
1 shared publication - Shi-Ting Feng
Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
1 shared publication - Xiaoqi Zhou
Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 58th the Second Zhongshan Road, Guangzhou 510080, China
1 shared publication
Latest Publications
- Open Access
- 22 January 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge
Background: Hepatocellular carcinoma (HCC) with hilar bile duct tumor thrombus (HBDTT) often mimic hilar cholangiocarcinoma (hilar CC). The purpose of this study is to analyze the Computed Tomography (CT) characteristics of HCC with HBDTT and to identify imaging features to aid its differentiation from hilar CC on enhanced CT.Methods: We retrospectively identified 58 cases with pathologically proved HCC with HBDTT between 2011 and 2018. Seventy-seven cases of pathologically proven hilar CCs were selected during the same period. The clinical features and CT findings of the two groups were reviewed and compared.Results: HCC with HBDTTs are more commonly found in men (87.9% vs 63.6%,p = 0.001) with lower age of onset (49.84 vs 58.61 years;p < 0.001) in comparison to hilar CCs. Positive correlation were identified between HCC with HBDTTs and chronic HBV infection (72.4% vs 11.7%;p < 0.001), increased serum AFP (67.2% vs 1.3%;p < 0.001), CA19–9 level (58.6% vs 85.7%;p < 0.001) and CEA level (3.4% vs 29.9%;p = 0.001), parenchymal lesion with intraductal lesion (100% vs 18.2%;p < 0.001), washout during the portal venous phase (84.5% vs 6.5%;p < 0.001), thickened bile duct wall (8.6% vs 93.5%;p < 0.001), intrahepatic vascular embolus (44.8% vs 7.8%;p < 0.001), splenomegaly (34.5% vs 2.6%,p < 0.001). A scoring system consisting of the five parameters obtained from characteristics mentioned above was trialed. The sensitivity and specificity for diagnosing HCC with HBDTT were 96.39, 100 and 92.5% respectively when the total score was 2 or more.Conclusions: HCC with HBDTTs are often distinguishable from hilar CCs based on washout during portal venous phase without thickened bile duct wall. HBV infection and serum AFP level facilitate the differentiation.
- 22 January 2020
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Open AccessHepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge
Background: Hepatocellular carcinoma (HCC) with hilar bile duct tumor thrombus (HBDTT) often mimic hilar cholangiocarcinoma (hilar CC). The purpose of this study is to analyze the Computed Tomography (CT) characteristics of HCC with HBDTT and to identify imaging features to aid its differentiation from hilar CC on enhanced CT.Methods: We retrospectively identified 58 cases with pathologically proved HCC with HBDTT between 2011 and 2018. Seventy-seven cases of pathologically proven hilar CCs were selected during the same period. The clinical features and CT findings of the two groups were reviewed and compared.Results: HCC with HBDTTs are more commonly found in men (87.9% vs 63.6%,p = 0.001) with lower age of onset (49.84 vs 58.61 years;p < 0.001) in comparison to hilar CCs. Positive correlation were identified between HCC with HBDTTs and chronic HBV infection (72.4% vs 11.7%;p < 0.001), increased serum AFP (67.2% vs 1.3%;p < 0.001), CA19–9 level (58.6% vs 85.7%;p < 0.001) and CEA level (3.4% vs 29.9%;p = 0.001), parenchymal lesion with intraductal lesion (100% vs 18.2%;p < 0.001), washout during the portal venous phase (84.5% vs 6.5%;p < 0.001), thickened bile duct wall (8.6% vs 93.5%;p < 0.001), intrahepatic vascular embolus (44.8% vs 7.8%;p < 0.001), splenomegaly (34.5% vs 2.6%,p < 0.001). A scoring system consisting of the five parameters obtained from characteristics mentioned above was trialed. The sensitivity and specificity for diagnosing HCC with HBDTT were 96.39, 100 and 92.5% respectively when the total score was 2 or more.Conclusions: HCC with HBDTTs are often distinguishable from hilar CCs based on washout during portal venous phase without thickened bile duct wall. HBV infection and serum AFP level facilitate the differentiation.